BIOREGENX, INC. Quarterly Operating Income (Loss) in USD from Q1 2022 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Bioregenx, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2022 to Q1 2024.
- Bioregenx, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$637K, a 246% decline year-over-year.
- Bioregenx, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$562K, a 150% decline year-over-year.
- Bioregenx, Inc. annual Operating Income (Loss) for 2023 was -$110K, a 40% decline from 2022.
- Bioregenx, Inc. annual Operating Income (Loss) for 2022 was -$78.3K, a 52.6% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)